Our research group aims to explore the expression levels of PD-L1 in DLBCL cells and also the mechanism underlying the effect of hsa-miR-28-5p on the development and therapeutic effect of DLBCL through the regulation of PD-L1 expression. This evidence concerns the gene CD274 and diffuse large B-cell lymphoma.